Spiros Kapralos

Recent publications · Crossref

5 total works indexed

1. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   · 2019 · cited 2,540x

2. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods

   · 2024 · cited 2,081x

3. The Future of Peptide‐based Drugs

   · 2012 · cited 1,780x

4. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

   · 2014 · cited 1,415x

5. Emerging pollutants in the environment: present and future challenges in biomonitoring, ecological risks and bioremediation

   · 2015 · cited 1,063x

via Crossref · CC0

Wikidata facts

Image